GlaxoSmithKline, maker of Avandia, tested a rival diabetes drug to figure out if a head-to-head trial was worth the risk. The conclusion: Avandia couldn't beat Actos.
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/07/13/128487457/avandia-maker-hid-data-that-put-diabetes-drug-in-bad-light?ft=1&f=103537970
Posted
Jul 13 2010, 10:33 AM
by
NPR Blogs: Shots - Health News Blog